Raymond James Financial
ABBV icon

Raymond James Financial’s AbbVie ABBV Stock Holding History

Raymond James Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.62B Buy
10,410,159
+805,810
+8% +$173M 0.71% 17
2026
Q1 		$2.09B Buy
9,604,349
+206,615
+2% +$45.8M 0.64% 20
2025
Q4 		$2.15B Sell
9,397,734
-159,967
-2% -$36.4M 0.67% 19
2025
Q3 		$2.21B Buy
9,557,701
+220,221
+2% +$44.8M 0.71% 18
2025
Q2 		$1.73B Buy
9,337,480
+2,753,312
+42% +$512M 0.6% 22
2025
Q1 		$1.38B Sell
6,584,168
-117,866
-2% -$22.9M 0.52% 27
2024
Q4 		$1.19B Buy
+6,702,034
New +$1.23B 0.44% 32

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Raymond James Financial's ABBV Position: Q2 2026 in Review

Raymond James Financial increased its AbbVie (ABBV) stake by 8.4% in Q2 2026, buying an estimated $173M and bringing the position to 10,410,159 shares worth $2.62B. The position accounts for 0.71% of the portfolio, ranked #17.

Raymond James Financial first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Raymond James Financial held 10,410,159 shares of AbbVie worth $2.62B as of Q2 2026.
  • Raymond James Financial bought 805,810 AbbVie shares in Q2 2026, an estimated $173M.
  • AbbVie made up 0.71% of Raymond James Financial's portfolio in Q2 2026, its #17 holding.
  • Raymond James Financial first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.